Skip to main content

Table 1 Prevalence of colorectal adenoma by demographic characteristic and risk factors among a nested case-control of IRAS Colon study participants

From: Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma

Characteristic

No Adenoma N = 97

Any Adenoma N = 97

p-value

Center

   

San Antonio, TX

26 (50.0)

26 (50.0)

1.00

San Luis Valley, CO

20 (50.0)

20 (50.0)

Oakland, CA

34 (50.0)

34 (50.0)

Los Angeles, CA

17 (50.0)

17 (50.0)

Sex

   

Male

33 (39.8)

50 (60.2)

0.01

Female

64 (57.7)

47 (42.3)

Age

   

<60

36 (62.1)

22 (37.9)

<0.01

60-69

42 (53.9)

36 (46.2)

70+

19 (32.8)

39 (67.2)

Race/Ethnicity

   

Non-Hispanic White

32 (43.2)

42 (56.8)

0.14

Black

35 (60.3)

23 (39.7)

Hispanic

30 (48.4)

32 (51.6)

Glucose tolerance at 1992-94

   

Normoglucose

54 (49.5)

55 (50.5)

0.68

Impaired glucose tolerance

20 (57.1)

15 (42.9)

Type II diabetes mellitus

23 (47.9)

25 (52.1)

BMI (kg/m2) at 2002-2004

   

Normal (<25kg/m2)

54 (50.0)

54 (50.0)

1.00

Overweight (25-29.9 kg/m2)

19 (50.0)

19 (50.0)

Obese (30 + kg/m2)

24 (50.0)

24 (50.0)

Smoking at 2002-2004

   

Never

51 (53.7)

44 (46.3)

0.32

Ever

46 (46.7)

53 (53.5)

Self reported previous screening

   

None

34 (54.8)

28 (45.2)

<0.01

Yes, without polyp

56 (54.9)

46 (45.1)

Yes, with polyp

7 (23.3)

23 (76.7)

NSAID use

   

None or Don’t Know

33 (45.2)

40 (54.8)

0.30

Yes

64 (52.9)

57 (47.1)

  1. Population data for participants included in the Insulin Resistance Atherosclerosis Study (IRAS). Details of the design and recruitment have been published previously [29]. Numbers in the parentheses represent the percentage of the total individuals included in each category. Statistical significance was determined used Chi-squared test.